| scholarly article | Q13442814 |
| P50 | author | Jack Tuszyński | Q16854345 |
| Francesco Gentile | Q61128417 | ||
| Khaled Barakat | Q64767247 | ||
| P2093 | author name string | Jack A Tuszynski | |
| Francesco Gentile | |||
| Khaled H Barakat | |||
| P2860 | cites work | Crystal structures of the structure-selective nuclease Mus81-Eme1 bound to flap DNA substrates | Q24294687 |
| The Protein Data Bank | Q24515306 | ||
| Amino acid substitution matrices from protein blocks | Q24563220 | ||
| DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy | Q27022940 | ||
| X-ray and biochemical anatomy of an archaeal XPF/Rad1/Mus81 family nuclease: similarity between its endonuclease domain and restriction enzymes | Q27640902 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif | Q28214697 | ||
| New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy. | Q53216317 | ||
| N-Hydroxyimides and hydroxypyrimidinones as inhibitors of the DNA repair complex ERCC1-XPF. | Q53558671 | ||
| Systematic Parameterization of Monovalent Ions Employing the Nonbonded Model | Q57675434 | ||
| Performance evaluation of amino acid substitution matrices | Q72589783 | ||
| Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours | Q74599371 | ||
| The generalized Born/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area | Q80790558 | ||
| Exhaustive matching of the entire protein sequence database | Q28263532 | ||
| Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction | Q28484387 | ||
| ZINC 15--Ligand Discovery for Everyone | Q28607096 | ||
| UniProt: a hub for protein information | Q29547457 | ||
| DNA repair pathways as targets for cancer therapy | Q29615572 | ||
| Making and breaking nucleic acids: two-Mg2+-ion catalysis and substrate specificity | Q29615987 | ||
| Comparison of methods for searching protein sequence databases. | Q30444045 | ||
| Property distribution of drug-related chemical databases. | Q30855791 | ||
| Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta. | Q30993534 | ||
| DNA repair mechanisms in dividing and non-dividing cells | Q34727858 | ||
| Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours. | Q34786179 | ||
| Clustering Molecular Dynamics Trajectories: 1. Characterizing the Performance of Different Clustering Algorithms | Q35860788 | ||
| Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born | Q35948015 | ||
| Variability in docking success rates due to dataset preparation | Q36095634 | ||
| ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. | Q36766916 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Rational Design of Particle Mesh Ewald Compatible Lennard-Jones Parameters for +2 Metal Cations in Explicit Solvent | Q37058615 | ||
| Structural and functional relationships of the XPF/MUS81 family of proteins | Q37179480 | ||
| DNA repair in mammalian cells : Nucleotide excision repair: variations on versatility | Q37372526 | ||
| Efficient detection of three-dimensional structural motifs in biological macromolecules by computer vision techniques | Q37629153 | ||
| Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. | Q37688903 | ||
| DNA repair inhibitors: the next major step to improve cancer therapy | Q38026149 | ||
| The role of DNA repair pathways in cisplatin resistant lung cancer | Q38280128 | ||
| Modelling DNA Repair Pathways: Recent Advances and Future Directions | Q38812023 | ||
| Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF. | Q38839750 | ||
| Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance | Q38877397 | ||
| Small molecule inhibitors of ERCC1-XPF protein-protein interaction synergize alkylating agents in cancer cells | Q39167525 | ||
| Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald | Q40291611 | ||
| Structure of an XPF endonuclease with and without DNA suggests a model for substrate recognition. | Q41376744 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | computational biology | Q177005 |
| virtual screening | Q4112105 | ||
| P577 | publication date | 2018-04-30 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Computational Characterization of Small Molecules Binding to the Human XPF Active Site and Virtual Screening to Identify Potential New DNA Repair Inhibitors Targeting the ERCC1-XPF Endonuclease | |
| P478 | volume | 19 |
| Q90642740 | Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments |
| Q64055258 | Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients |
| Q60916341 | Function and Interactions of ERCC1-XPF in DNA Damage Response |
| Q57812384 | Homology Model and Docking-Based Virtual Screening for Ligands of Human Dyskerin as New Inhibitors of Telomerase for Cancer Treatment |
Search more.